Literature DB >> 3014201

Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.

J B Michel, J C Dussaule, L Choudat, C Auzan, D Nochy, P Corvol, J Menard.   

Abstract

In order to investigate the consequences of antihypertensive therapy on hormonal and renal parameters in one-clip, two kidney renovascular hypertension, we compared the effects of converting enzyme inhibition (CEI) with those of tripletherapy (clonidine, dihydralazine and furosemide) in this experimental model in rats. The treatment period was initiated four weeks after application of the clip and was continued for five weeks. In plasma, renin was increased and renin substrate was negatively correlated to plasma renin. Hypertension was associated with activation of the renin angiotensin system in both plasma and kidney. The degree of activation of the renin-angiotensin system in the clipped kidney and its suppression in the unclipped kidney was evaluated by two methods, renal renin content and semi-quantification of juxtaglomerular hyperplasia by immunofluorescent renin. These two methods were correlated. During the treatment period, average systolic blood pressure was 144 +/- 13 mmHg in the CEI treated group (HT1) which was not significantly different from the value found in the sham-operated group (139 +/- 4 mmHg; C2). Blood pressure, however, was lowered only to 173 +/- 18 mmHg in the group treated with tripletherapy (HT2). In control hypertensive animals, the wt of the clipped kidney did not decrease whereas significant hypertrophy was present in the unclipped kidney. Tripletherapy did not alter this relationship, whereas converting enzyme inhibition decreased kidney wt in the clipped kidney and increased further the hypertrophy of the contralateral unclipped kidney. A histological examination revealed that hypertensive microangiopathy was a predominant feature in the unclipped kidney of the untreated hypertensive group and of the group treated with tripletherapy, these lesions were completely absent in the CEI treated group. In the CEI treated group, however, ischemic lesions during this treatment were found to be decreased in the contralateral unclipped kidney and increased in the clipped kidney by comparison with untreated hypertensive rats. These renal lesions observed in the clipped kidney were most likely related to the normalization of blood pressure or to a disturbance of intrarenal mechanisms normally mediated by the renin-angiotensin system during stenosis of a renal artery.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014201     DOI: 10.1038/ki.1986.101

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Iron restriction in renovascular hypertension.

Authors:  Masayuki Tanemoto
Journal:  Hypertens Res       Date:  2017-03-02       Impact factor: 3.872

2.  Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats.

Authors:  D Rousseau; C Héliès-Toussaint; D Raederstorff; D Moreau; A Grynberg
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

Review 3.  Perindopril. A review of its pharmacokinetics and clinical pharmacology.

Authors:  R J Macfadyen; K R Lees; J L Reid
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 4.  Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  P A Todd; A Fitton
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

5.  Co-existence of renin-like immunoreactivity in the rat maternal and fetal neocortex.

Authors:  P P Sood; M Panigel; R Wegmann
Journal:  Neurochem Res       Date:  1989-06       Impact factor: 3.996

Review 6.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

7.  Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension.

Authors:  Sandrine Delbosc; Mounsif Haloui; Liliane Louedec; Morgan Dupuis; Myriam Cubizolles; Vladimir N Podust; Eric T Fung; Jean-Baptiste Michel; Olivier Meilhac
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 8.  Angiotensin and the remodelling of the myocardium.

Authors:  K T Weber; J S Janicki
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

9.  Renin, endothelial NO synthase and endothelin gene expression in the 2kidney-1clip Goldblatt model of long-term renovascular hypertension.

Authors:  S W Reinhold; D C Uihlein; C A Böger; S Kloiber; K Frölich; T Bergler; B Banas; F Schweda; B K Krämer
Journal:  Eur J Med Res       Date:  2009       Impact factor: 2.175

Review 10.  Renal artery stenosis and cardiovascular risk.

Authors:  Shahzad Shafique; Aldo J Peixoto
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-03       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.